Aberrant activation of the NF-κB pathway (e.g., elevated expression of TNFRSF21 and c-Rel) has been recognized as a hallmark of NKTCL [91]. The gene discussed is NFKB1; the disease is extranodal nasal NK/T cell lymphoma.